Understanding Biosimilar Insulin and the Role of Rapid Acting Insulin in Intensification
Free
Log In
Overview
The discussion will cover the safety and efficacy of biosimilar insulins, when it is appropriate to add a rapid acting insulin to intensify therapy in Type 2 Diabetes patients and basics of basal-bolus therapy.
This webinar is for Endocrinologists, Internal Medicine, GP, Family Medicine, Diabetologists
This Activity for
- Resident / Fellow
- Physician
What I will learn?
By the end of the course, you should be able to:
●Understand the safety and efficacy of biosimilar insulin
●Understand when insulin intensification is required in a T2DM patient
●Understand the role of rapid acting insulin in intensification
●Understand basal-bolus therapy
About Organizer
- Virtual Medical Academy
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
| Understanding Biosimilar Insulin and the Role of Rapid Acting Insulin in Intensification Certificate | Certificate | Free |
VAT 15% Included